BioSig Technologies, Inc.
BSGM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $209,222 | $349,210 | $180,904 | $747,316 |
| - Cash | $142 | $190 | $357 | $11,659 |
| + Debt | $102 | $452 | $765 | $656 |
| Enterprise Value | $209,182 | $349,472 | $181,312 | $736,313 |
| Revenue | $40 | $18 | $286 | $441 |
| % Growth | 122.2% | -93.7% | -35.1% | – |
| Gross Profit | $40 | $18 | $229 | $242 |
| % Margin | 100% | 100% | 80.1% | 54.9% |
| EBITDA | -$12,421 | -$28,151 | -$26,972 | -$33,213 |
| % Margin | -31,052.5% | -156,394.4% | -9,430.8% | -7,531.3% |
| Net Income | -$10,330 | -$29,041 | -$27,271 | -$31,362 |
| % Margin | -25,825% | -161,338.9% | -9,535.3% | -7,111.6% |
| EPS Diluted | -0.074 | -0.4 | -0.63 | -0.94 |
| % Growth | 81.6% | 36.5% | 33% | – |
| Operating Cash Flow | -$4,758 | -$17,313 | -$21,705 | -$26,399 |
| Capital Expenditures | $0 | -$186 | -$168 | -$542 |
| Free Cash Flow | -$4,758 | -$17,499 | -$21,873 | -$26,941 |